ArticleTranslational oncology2021

Optimizing outcomes in HCC: Comment on "optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis" by Jiang et al.

Alessandro RizzoPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.